FDA Inspection 711361 — Prescript Pharmaceuticals, Inc.

Prescript Pharmaceuticals, Inc. — FEI 1000135824

The FDA completed an inspection of Prescript Pharmaceuticals, Inc. on March 3, 2011 in Pleasanton, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
March 3, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pleasanton, CA (United States)